Search results
Jump to navigation
Jump to search
Page title matches
- ! Growth factor!! Chemotherapeutic agent !! Malignancy | [[Endothelial growth factor]]s || ||1 KB (171 words) - 09:06, 9 September 2020
- 107 bytes (11 words) - 17:17, 13 May 2023
- 232 bytes (29 words) - 09:16, 9 September 2020
- '''Hepatocyte growth factor receptor''' (HGFR) is a [[receptor tyrosine kinase]] that is essential for908 bytes (127 words) - 01:01, 13 January 2009
- ...sforming growth factor alpha]], amphiregulin, and heparin-binding EGF-like growth factor. The binding of ligand to the receptor causes activation of its intrinsic [1 KB (208 words) - 07:56, 1 May 2010
- 172 bytes (24 words) - 01:06, 13 January 2009
- ...ulates [[cell]] growth and [[differentiation]] by binding with [[epidermal growth factor]]s.162 bytes (19 words) - 11:56, 4 December 2010
Page text matches
- ! Growth factor!! Chemotherapeutic agent !! Malignancy | [[Endothelial growth factor]]s || ||1 KB (171 words) - 09:06, 9 September 2020
- ...ulates [[cell]] growth and [[differentiation]] by binding with [[epidermal growth factor]]s.162 bytes (19 words) - 11:56, 4 December 2010
- #redirect [[Hepatocyte growth factor receptor]]47 bytes (5 words) - 00:19, 13 January 2009
- #redirect [[Hepatocyte growth factor receptor]]47 bytes (5 words) - 01:07, 13 January 2009
- #redirect [[Hepatocyte growth factor receptor]]47 bytes (5 words) - 01:07, 13 January 2009
- #redirect [[Hepatocyte growth factor receptor]]47 bytes (5 words) - 01:08, 13 January 2009
- {{r|Epidermal growth factor receptor||**}} {{r|Platelet-derived growth factor receptor||**}}2 KB (234 words) - 00:42, 13 January 2009
- [[Cancer|Antineoplastic agent]] [[antibody]] that blocks [[epidermal growth factor]] (EGF) [[receptor]]s (EGFRs).149 bytes (16 words) - 11:35, 4 December 2010
- ...sforming growth factor alpha]], amphiregulin, and heparin-binding EGF-like growth factor. The binding of ligand to the receptor causes activation of its intrinsic [1 KB (208 words) - 07:56, 1 May 2010
- '''Hepatocyte growth factor receptor''' (HGFR) is a [[receptor tyrosine kinase]] that is essential for908 bytes (127 words) - 01:01, 13 January 2009
- {{r|Insulin-like growth factor}} (IGF, also somatomedin)1 KB (175 words) - 08:13, 8 November 2010
- ...aive lymphocytes. Other terms include Lymphocyte Mitogenic Factor, T-Cell Growth Factor, Thymocyte Stimulating Factor and T-Cell Stimulating Factor.<ref>{{MeSH}}</1 KB (158 words) - 01:09, 19 August 2010
- ...y or Akt is an important downstream signaling component of tyrosine kinase growth factor and G-coupled receptors. Akt/PKB is activated by phosphorylation at two dis304 bytes (43 words) - 02:10, 16 May 2009
- ...sive homology to and can heterodimerize with the EGF receptor ([[epidermal growth factor receptor]]), the [[erbB-3 receptor]] and the erbB-4 receptor. "<ref>{{MeSH} ...screening with v-ErbB (3) and has the highest homology to the [[epidermal growth factor receptor | EGFR]] among ErbB family members. It is mostly related to EGFR i2 KB (308 words) - 06:03, 16 July 2010
- ...that blocks [[epidermal growth factor receptor|receptors]] for [[epidermal growth factor]]."<ref>{{MeSH}}</ref> ...s trial did not include patients whose cancers did not express [epidermal growth factor receptor]].3 KB (353 words) - 01:59, 23 September 2010
- *[[IGF-1]] and other [[insulin-like growth factor]]s2 KB (286 words) - 02:03, 2 June 2009
- {{r|Insulin-like growth factor}}2 KB (295 words) - 10:18, 30 May 2009
- ...actor receptor|ErbB-1 receptor]], and [[ErbB-2 receptor]] (Human Epidermal growth factor Receptor 2, HER2, HER-2).2 KB (273 words) - 11:27, 4 May 2010
- '''Bevacizumab''' is an "anti-VEGF (i.e., [[vascular endothelial growth factor A]]) <ref>{{citation | title = Vascular endothelial growth factor A isoform a [Homo sapiens]3 KB (376 words) - 14:53, 17 July 2010
- ...ine]] rather than endocrine manner."<ref>{{MeSH}}</ref> Examples include [[growth factor]]s,[[interferon]]s, [[interleukin]]s, and [[tumor necrosis factor]].7 KB (926 words) - 17:47, 19 April 2010